ÂsÄý³æ­Ó¤å³¹
sparc10
Power Member
 
sparc10ªº¤jÀY·Ó
 

¥[¤J¤é´Á: Jun 2003
±zªº¦í§}: CC BY-NC-ND 4.0±ÂÅv
¤å³¹: 689
# ¦pªG§A­Ì¤£Äݩ󤽶O¬Ì­]±µºØ¹ï¶H¡A¤]¤£·|¥X°ê¤u§@¡B¯d¾Ç©Î´NÂå¡A«h¬Ý¬Ý¦Û¤v¡m¦P¦íªÌ¡n¬O§_²Ä¤@Ãþ¦Ü²Ä¤TÃþ¤§¤H¡C
# ¦pªG¬O¡A§A¤]¯à¥h¥´¤½¶O¬Ì­]¡C

¤½¶O¬Ì­]±µºØ¹ï¶H²M³æ
https://www.cdc.gov.tw/Category/Pag...51P_aYADuh3rTBA

5¤ë3¤é°_¶}©ñ¹ê¬I­pµe²Ä¤@Ãþ¦Ü²Ä¤TÃþ<¦P¦íªÌ>¥H¤Î©Ò¦³Âå¨Æ¾÷ºc¤u§@¤H­û±µºØCOVID-19¬Ì­]
https://www.cdc.gov.tw/Bulletin/Det...rzUGCA?typeid=9

# «nÁú«ÅºÙ¡G½÷·ç»PAZ®ÄªG±µªñ¡I
S.Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shot
https://www.reuters.com/world/asia-...hot-2021-05-05/

# Âå¾Ç´Á¥ZThe Lancet´£¨ì¡G½÷·ç»PAZ®ÄªG³£¤£¿ù¡C
The BNT162b2 mRNA (Pfizer¡VBioNTech) and ChAdOx1 nCoV-19 (Oxford¡VAstraZeneca) COVID-19 vaccines
have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other countries.
https://www.thelancet.com/journals/...0677-2/fulltext
ÂÂ 2021-05-11, 07:28 PM #39
¦^À³®É¤Þ¥Î¦¹¤å³¹
sparc10Â÷½u¤¤